PT Kimia Farma Tbk Statistics

Total Valuation

PT Kimia Farma Tbk has a market cap or net worth of IDR 3.34 trillion. The enterprise value is 10.99 trillion.

Market Cap	3.34T
Enterprise Value	10.99T

Important Dates

The next estimated earnings date is Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

PT Kimia Farma Tbk has 5.57 billion shares outstanding. The number of shares has decreased by -0.16% in one year.

Current Share Class	n/a
Shares Outstanding	5.57B
Shares Change (YoY)	-0.16%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	4.44%
Float	566.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.33
PB Ratio	0.63
P/TBV Ratio	0.65
P/FCF Ratio	303.60
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.35
EV / Sales	1.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	998.90

Financial Position

The company has a current ratio of 0.68, with a Debt / Equity ratio of 1.36.

Current Ratio	0.68
Quick Ratio	0.34
Debt / Equity	1.36
Debt / EBITDA	n/a
Debt / FCF	706.88
Interest Coverage	-3.15

Financial Efficiency

Return on equity (ROE) is -29.34% and return on invested capital (ROIC) is -8.35%.

Return on Equity (ROE)	-29.34%
Return on Assets (ROA)	-6.91%
Return on Capital (ROIC)	-8.35%
Revenue Per Employee	944.18M
Profits Per Employee	-161.50M
Employee Count	11,461
Asset Turnover	0.54
Inventory Turnover	2.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.86% in the last 52 weeks. The beta is 0.26, so PT Kimia Farma Tbk's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	-15.86%
50-Day Moving Average	682.90
200-Day Moving Average	716.23
Relative Strength Index (RSI)	33.34
Average Volume (20 Days)	514,870

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PT Kimia Farma Tbk had revenue of IDR 10.11 trillion and -1,730.03 billion in losses. Loss per share was -311.07.

Revenue	10.11T
Gross Profit	2.30T
Operating Income	-2,065.13B
Pretax Income	-2,651.64B
Net Income	-1,730.03B
EBITDA	-1,536.65B
EBIT	-2,065.13B
Loss Per Share	-311.07

Full Income Statement

Balance Sheet

The company has 505.11 billion in cash and 7.78 trillion in debt, giving a net cash position of -7,271.29 billion or -1,306.24 per share.

Cash & Cash Equivalents	505.11B
Total Debt	7.78T
Net Cash	-7,271.29B
Net Cash Per Share	-1,306.24
Equity (Book Value)	5.71T
Book Value Per Share	957.72
Working Capital	-2,518.24B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 582.41 billion and capital expenditures -571.41 billion, giving a free cash flow of 11.00 billion.

Operating Cash Flow	582.41B
Capital Expenditures	-571.41B
Free Cash Flow	11.00B
FCF Per Share	1.98

Full Cash Flow Statement

Margins

Gross margin is 22.69%, with operating and profit margins of -20.42% and -17.11%.

Gross Margin	22.69%
Operating Margin	-20.42%
Pretax Margin	-26.22%
Profit Margin	-17.11%
EBITDA Margin	-15.19%
EBIT Margin	-20.42%
FCF Margin	0.11%

Dividends & Yields

PT Kimia Farma Tbk does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.16%
Shareholder Yield	0.16%
Earnings Yield	-51.84%
FCF Yield	0.33%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PT Kimia Farma Tbk has an Altman Z-Score of 0.18. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.18
Piotroski F-Score	n/a